Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05532423 · ClinicalTrials.gov registry record · Early Phase 1
Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome
A Early Phase 1 study, sponsored by Penn State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 22
- Enrollment target
NCT05532423: Completed Early Phase 1 study, sponsored by Penn State University.
NCT05532423 is a Early Phase 1 study that has completed, run by Penn State University. The registered enrollment target is 22 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05532423, a Early Phase 1 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if beetroot juice consumption can improve cognitive performance and brain vascular function in individuals with metabolic syndrome
Primary Outcome
Reaction time of responses for each trial type (0-back, 1-back, 2-back, and 3-back)
Interventions
- DRUG Beetroot Juice - Active
- DRUG beetroot juice - Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2024-08-01 |
| Phase | Early Phase 1 |
What the finished NCT05532423 record still lists
NCT05532423 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 2 interventions - of which Beetroot Juice - Active is the first listed.
NCT05532423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05532423 about?
NCT05532423 is a clinical study titled "Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome". The purpose of this study is to determine if beetroot juice consumption can improve cognitive performance and brain vascular function in individuals with metabolic syndrome
What is the current status of trial NCT05532423?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 22 participants. The study started on 2022-12-01. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT05532423?
The interventions under investigation include: Beetroot Juice - Active (DRUG), beetroot juice - Placebo (DRUG).
Who is sponsoring clinical trial NCT05532423?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05532423's enrollment target sits among peer trials
22 1104th of 2000 higher than 872 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI